Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early experience with daratumumab-containing regimens in patients with light-chain cardiac amyloidosis.
Morikawa K, Izumiya Y, Takashio S, Kawano Y, Oguni T, Kuyama N, Oike F, Yamamoto M, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Matsuzawa Y, Usuku H, Yamamoto E, Ueda M, Tsujita K. Morikawa K, et al. Among authors: kuyama n. J Cardiol. 2024 Nov 20:S0914-5087(24)00216-8. doi: 10.1016/j.jjcc.2024.11.003. Online ahead of print. J Cardiol. 2024. PMID: 39577830
Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor-Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor-p65-Signal Transducer and Activator of Transcription 3 Complex.
Kuyama N, Araki S, Kaikita K, Nakanishi N, Nakashima N, Hanatani S, Arima Y, Yamamoto M, Nakamura T, Yamamoto E, Matsushita K, Matsui K, Tsujita K. Kuyama N, et al. J Am Heart Assoc. 2024 Sep 17;13(18):e030941. doi: 10.1161/JAHA.123.030941. Epub 2024 Sep 9. J Am Heart Assoc. 2024. PMID: 39248263 Free article.
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.
Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS; HELIOS-B Trial Investigators. Fontana M, et al. N Engl J Med. 2024 Aug 30. doi: 10.1056/NEJMoa2409134. Online ahead of print. N Engl J Med. 2024. PMID: 39213194
Subclinical leaflet thrombus in patients with severe aortic stenosis and atrial fibrillation -ENRICH-AF TAVI study.
Otsuka Y, Ishii M, Tabata N, Oda S, Kidoh M, Shirahama Y, Egashira K, Kuyama N, Rokutanda T, Noda K, Horio E, Sakamoto T, Kudo T, Shimomura H, Ikemoto T, Tsunoda R, Nakamura T, Matsui K, Kaikita K, Tsujita K; ENRICH AF TAVI Investigators. Otsuka Y, et al. Among authors: kuyama n. Sci Rep. 2024 Jun 28;14(1):14902. doi: 10.1038/s41598-024-65600-5. Sci Rep. 2024. PMID: 38942790 Free PMC article.
Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia.
Kanazawa H, Takashio S, Hoshiyama T, Ito M, Kaneko S, Kiyama T, Kawahara Y, Sumi H, Tsuruta Y, Kuyama N, Hirakawa K, Ishii M, Tabata N, Yamanaga K, Fujisue K, Hanatani S, Sueta D, Arima Y, Araki S, Matsuzawa Y, Usuku H, Nakamura T, Yamamoto E, Soejima H, Matsushita K, Tsujita K. Kanazawa H, et al. Among authors: kuyama n. Europace. 2024 Jun 3;26(6):euae155. doi: 10.1093/europace/euae155. Europace. 2024. PMID: 38934242 Free PMC article.
27 results